Cognitive Behavioral Therapy for Social Anxiety Disorder
(I-FOCUS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand why some people fully benefit from cognitive behavioral therapy (CBT) for social anxiety disorder while others do not. Participants will attend twelve weekly sessions of CBT, a type of talk therapy that helps change negative thought patterns. The trial seeks individuals between 18 and 45 years old who have social anxiety or body dysmorphic disorder and are seeking treatment. Participants must be fluent in English and willing to consent to join the study. As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance future treatment strategies.
Will I have to stop taking my current medications?
The trial requires that participants stop taking psychotropic medications, except for antidepressants, which must be taken at a stable dose for at least 3 months before starting the study.
What prior data suggests that cognitive behavioral therapy is safe for treating social anxiety disorder?
Research has shown that Cognitive Behavioral Therapy (CBT) safely treats various mental health issues. It effectively helps individuals manage problems like anxiety and stress. CBT works by altering negative thoughts and behaviors, which can reduce anxiety over time.
No reports of serious side effects from CBT exist. Most individuals tolerate it well, and since it doesn't involve medication, it has fewer side effects than drug treatments. This makes it a safe option for many seeking to improve their mental health.12345Why are researchers excited about this trial?
Cognitive Behavioral Therapy (CBT) is unique because it offers a structured approach to treating Social Anxiety Disorder by helping individuals identify and change negative thought patterns and behaviors. Unlike medications, which typically aim to manage symptoms, CBT empowers individuals to develop coping skills that can lead to long-term improvements and potentially reduce the need for medication. Researchers are excited about CBT because it emphasizes personal growth and resilience, offering a non-pharmacological option that can be tailored to each person's specific challenges and experiences.
What evidence suggests that cognitive behavioral therapy is effective for social anxiety disorder?
Studies have shown that cognitive behavioral therapy (CBT), which participants in this trial will receive, effectively reduces symptoms of social anxiety disorder (SAD). Reviews combining results from multiple studies confirm CBT's success in treating SAD. Research indicates that symptoms can decrease significantly after therapy, with noticeable improvements continuing for up to a year or more. Effect sizes, ranging from 0.9 to 1.2, measure the strength of CBT's impact, demonstrating a strong positive effect. Overall, research supports CBT as a helpful treatment for reducing social anxiety symptoms.678910
Who Is on the Research Team?
Angela Fang, PhD
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for individuals with conditions like Body Dysmorphic Disorder, Social Anxiety Disorder, or Generalized Anxiety Disorder. It aims to understand why Cognitive Behavioral Therapy (CBT) works well for some but not others.Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-treatment
Baseline assessments including neuroimaging scans, clinical interviews, and self-report assessments
Treatment
Participants receive 12 weekly sessions of individual cognitive behavioral therapy and complete 4 fMRI scans
Post-treatment
Post-treatment assessments including neuroimaging scans and clinical interviews
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy
Cognitive Behavioral Therapy is already approved in European Union, United States, Canada for the following indications:
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
- Substance use disorders
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator